Literature DB >> 25858253

Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.

Wuzhou Wan1, Qian Liu1, Michail S Lionakis2, Ana Paula M P Marino1, Stasia A Anderson3, Muthulekha Swamydas2, Philip M Murphy4.   

Abstract

AIMS: Atypical chemokine receptor 1 (Ackr1; previously known as the Duffy antigen receptor for chemokines or Darc) is thought to regulate acute inflammatory responses in part by scavenging inflammatory CC and CXC chemokines; however, evidence for a role in chronic inflammation has been lacking. Here we investigated the role of Ackr1 in chronic inflammation, in particular in the setting of atherogenesis, using the apolipoprotein E-deficient (ApoE(-/-)) mouse model. METHODS AND
RESULTS: Ackr1(-/-)ApoE(-/-) and Ackr1(+/+)ApoE(-/-) littermates were obtained by crossing ApoE(-/-) mice and Ackr1(-/-) mice on a C57BL/6J background. Ackr1 (+/+)ApoE(-/-)mice fed a Western diet up-regulated Ackr1 expression in the aorta and had markedly increased atherosclerotic lesion size compared with Ackr1(-/-)ApoE(-/-) mice. This difference was observed in both the whole aorta and the aortic root in both early and late stages of the model. Ackr1 deficiency did not affect serum cholesterol levels or macrophage, collagen or smooth muscle cell content in atherosclerotic plaques, but significantly reduced the expression of Ccl2 and Cxcl1 in the whole aorta of ApoE(-/-) mice. In addition, Ackr1 deficiency resulted in a modest decrease in T cell subset frequency and inflammatory mononuclear phagocyte content in aorta and blood in the model.
CONCLUSIONS: Ackr1 deficiency appears to be protective in the ApoE knockout model of atherogenesis, but it is associated with only modest changes in cytokine and chemokine expression as well as T-cell subset frequency and inflammatory macrophage content. Published by Oxford University Press on behalf of the European Society of Cardiology 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Atherosclerosis; Chemokine receptor; Inflammation; Leukocytes

Mesh:

Substances:

Year:  2015        PMID: 25858253      PMCID: PMC4447808          DOI: 10.1093/cvr/cvv124

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  29 in total

1.  Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC).

Authors:  T C Dawson; A B Lentsch; Z Wang; J E Cowhig; A Rot; N Maeda; S C Peiper
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

Review 2.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

3.  Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo.

Authors:  Janet S Lee; Charles W Frevert; Mark M Wurfel; Stephen C Peiper; Venus A Wong; Kimberley K Ballman; John T Ruzinski; Johng S Rhim; Thomas R Martin; Richard B Goodman
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

Review 4.  Regulation of atherogenesis by chemokines and chemokine receptors.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-12-07       Impact factor: 4.291

5.  The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.

Authors:  Monika Pruenster; Liesbeth Mudde; Paula Bombosi; Svetla Dimitrova; Marion Zsak; Jim Middleton; Ann Richmond; Gerard J Graham; Stephan Segerer; Robert J B Nibbs; Antal Rot
Journal:  Nat Immunol       Date:  2008-12-07       Impact factor: 25.606

Review 6.  Immune and inflammatory mechanisms of atherosclerosis (*).

Authors:  Elena Galkina; Klaus Ley
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

7.  Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection.

Authors:  P'ng Loke; Iain Gallagher; Meera G Nair; Xingxing Zang; Frank Brombacher; Markus Mohrs; James P Allison; Judith E Allen
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 8.  Chemokines: established and novel targets in atherosclerosis.

Authors:  Rory R Koenen; Christian Weber
Journal:  EMBO Mol Med       Date:  2011-10-28       Impact factor: 12.137

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

10.  Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines.

Authors:  Igor Novitzky-Basso; Antal Rot
Journal:  Front Immunol       Date:  2012-08-17       Impact factor: 7.561

View more
  10 in total

Review 1.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

2.  The Duffy antigen receptor for chemokines regulates asthma pathophysiology.

Authors:  D G Chapman; E B Mougey; J L Van der Velden; K G Lahue; M Aliyeva; N Daphtary; K L George; S M Hoffman; R W Schneider; R P Tracy; G S Worthen; M E Poynter; S P Peters; J J Lima; Y M W Janssen-Heininger; C G Irvin
Journal:  Clin Exp Allergy       Date:  2017-06-09       Impact factor: 5.018

3.  Differential DARC/ACKR1 expression distinguishes venular from non-venular endothelial cells in murine tissues.

Authors:  Aude Thiriot; Carolina Perdomo; Guiying Cheng; Igor Novitzky-Basso; Sara McArdle; Jamie K Kishimoto; Olga Barreiro; Irina Mazo; Robinson Triboulet; Klaus Ley; Antal Rot; Ulrich H von Andrian
Journal:  BMC Biol       Date:  2017-05-19       Impact factor: 7.431

Review 4.  G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis.

Authors:  Emiel P C van der Vorst; Linsey J F Peters; Madeleine Müller; Selin Gencer; Yi Yan; Christian Weber; Yvonne Döring
Journal:  Front Pharmacol       Date:  2019-05-22       Impact factor: 5.810

5.  Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters show stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slowing It.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Irina Chadaeva; Ekaterina Sharypova; Irina Drachkova; Dmitry Oshchepkov; Petr Ponomarenko; Ludmila Savinkova; Evgeniya Oshchepkova; Maria Nazarenko; Nikolay Kolchanov
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

6.  Single-Cell Analysis Uncovers Osteoblast Factor Growth Differentiation Factor 10 as Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation Associated with Plaque Rupture in Human Carotid Artery Disease.

Authors:  Karim J Brandt; Fabienne Burger; Daniela Baptista; Aline Roth; Rafaela Fernandes da Silva; Fabrizio Montecucco; Francois Mach; Kapka Miteva
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

Review 7.  Obesity and the Bidirectional Risk of Cancer and Cardiovascular Diseases in African Americans: Disparity vs. Ancestry.

Authors:  Avirup Guha; Xiaoling Wang; Ryan A Harris; Anna-Gay Nelson; David Stepp; Zachary Klaassen; Priyanka Raval; Jorge Cortes; Steven S Coughlin; Vladimir Y Bogdanov; Justin X Moore; Nihar Desai; D Douglas Miller; Xin-Yun Lu; Ha Won Kim; Neal L Weintraub
Journal:  Front Cardiovasc Med       Date:  2021-10-18

Review 8.  Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response.

Authors:  Raffaella Bonecchi; Gerard J Graham
Journal:  Front Immunol       Date:  2016-06-10       Impact factor: 7.561

9.  Understanding seasonal weight loss tolerance in dairy goats: a transcriptomics approach.

Authors:  José Ricardo Parreira; Lorenzo Enrique Hernández-Castellano; Anastasio Argüello; Juan Capote; Noemí Castro; Susana de Sousa Araújo; André Martinho de Almeida
Journal:  BMC Genomics       Date:  2020-09-14       Impact factor: 3.969

10.  Deletion of the Duffy antigen receptor for chemokines (DARC) promotes insulin resistance and adipose tissue inflammation during high fat feeding.

Authors:  Tyler W Benson; Daniel S Weintraub; Matthew Crowe; Nicole K H Yiew; Orishebawo Popoola; Ajay Pillai; Joel Joseph; Krystal Archer; Charlotte Greenway; Tapan K Chatterjee; James Mintz; David W Stepp; Brian K Stansfield; Weiqin Chen; Julia Brittain; Vladimir Y Bogdanov; Yan Gao; James G Wilson; Yaoliang Tang; Ha Won Kim; Neal L Weintraub
Journal:  Mol Cell Endocrinol       Date:  2018-01-16       Impact factor: 4.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.